These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

233 related items for PubMed ID: 15050603

  • 41. Voxel-based assessment of differences in damage and distribution of white matter lesions between patients with primary progressive and relapsing-remitting multiple sclerosis.
    Di Perri C, Battaglini M, Stromillo ML, Bartolozzi ML, Guidi L, Federico A, De Stefano N.
    Arch Neurol; 2008 Feb; 65(2):236-43. PubMed ID: 18268194
    [Abstract] [Full Text] [Related]

  • 42. A whole brain MR spectroscopy study from patients with Alzheimer's disease and mild cognitive impairment.
    Falini A, Bozzali M, Magnani G, Pero G, Gambini A, Benedetti B, Mossini R, Franceschi M, Comi G, Scotti G, Filippi M.
    Neuroimage; 2005 Jul 15; 26(4):1159-63. PubMed ID: 15878675
    [Abstract] [Full Text] [Related]

  • 43. In vivo assessment of cervical cord damage in MS patients: a longitudinal diffusion tensor MRI study.
    Agosta F, Absinta M, Sormani MP, Ghezzi A, Bertolotto A, Montanari E, Comi G, Filippi M.
    Brain; 2007 Aug 15; 130(Pt 8):2211-9. PubMed ID: 17535835
    [Abstract] [Full Text] [Related]

  • 44. Discordant white matter N-acetylasparate and diffusion MRI measures suggest that chronic metabolic dysfunction contributes to axonal pathology in multiple sclerosis.
    Cader S, Johansen-Berg H, Wylezinska M, Palace J, Behrens TE, Smith S, Matthews PM.
    Neuroimage; 2007 May 15; 36(1):19-27. PubMed ID: 17398118
    [Abstract] [Full Text] [Related]

  • 45. Brain atrophy evolution and lesion load accrual in multiple sclerosis: a 2-year follow-up study.
    Tedeschi G, Dinacci D, Comerci M, Lavorgna L, Savettieri G, Quattrone A, Livrea P, Patti F, Morra VB, Servillo G, Orefice G, Paciello M, Prinster A, Coniglio G, Bonavita S, Di Costanzo A, Bellacosa A, Valentino P, Quarantelli M, Brunetti A, Salemi G, D'Amelio M, Simone I, Salvatore M, Bonavita V, Alfano B.
    Mult Scler; 2009 Feb 15; 15(2):204-11. PubMed ID: 18987104
    [Abstract] [Full Text] [Related]

  • 46. (1)H MR spectroscopy of the brain in multiple sclerosis subtypes with analysis of the metabolite concentrations in gray and white matter: initial findings.
    Sijens PE, Mostert JP, Oudkerk M, De Keyser J.
    Eur Radiol; 2006 Feb 15; 16(2):489-95. PubMed ID: 16028056
    [Abstract] [Full Text] [Related]

  • 47. Serial proton magnetic resonance spectroscopic imaging, contrast-enhanced magnetic resonance imaging, and quantitative lesion volumetry in multiple sclerosis.
    Narayana PA, Doyle TJ, Lai D, Wolinsky JS.
    Ann Neurol; 1998 Jan 15; 43(1):56-71. PubMed ID: 9450769
    [Abstract] [Full Text] [Related]

  • 48. 1H-MRS quantification of tNA and tCr in patients with multiple sclerosis: a meta-analytic review.
    Caramanos Z, Narayanan S, Arnold DL.
    Brain; 2005 Nov 15; 128(Pt 11):2483-506. PubMed ID: 16230321
    [Abstract] [Full Text] [Related]

  • 49. A multicenter in vivo proton-MRS study of HIV-associated dementia and its relationship to age.
    Chang L, Lee PL, Yiannoutsos CT, Ernst T, Marra CM, Richards T, Kolson D, Schifitto G, Jarvik JG, Miller EN, Lenkinski R, Gonzalez G, Navia BA, HIV MRS Consortium.
    Neuroimage; 2004 Dec 15; 23(4):1336-47. PubMed ID: 15589098
    [Abstract] [Full Text] [Related]

  • 50. Evidence of thalamic gray matter loss in pediatric multiple sclerosis.
    Mesaros S, Rocca MA, Absinta M, Ghezzi A, Milani N, Moiola L, Veggiotti P, Comi G, Filippi M.
    Neurology; 2008 Mar 25; 70(13 Pt 2):1107-12. PubMed ID: 18272867
    [Abstract] [Full Text] [Related]

  • 51. Correlation of global N-acetyl aspartate with cognitive impairment in multiple sclerosis.
    Mathiesen HK, Jonsson A, Tscherning T, Hanson LG, Andresen J, Blinkenberg M, Paulson OB, Sorensen PS.
    Arch Neurol; 2006 Apr 25; 63(4):533-6. PubMed ID: 16606765
    [Abstract] [Full Text] [Related]

  • 52. Combination of CSF N-acetylaspartate and neurofilaments in multiple sclerosis.
    Teunissen CE, Iacobaeus E, Khademi M, Brundin L, Norgren N, Koel-Simmelink MJ, Schepens M, Bouwman F, Twaalfhoven HA, Blom HJ, Jakobs C, Dijkstra CD.
    Neurology; 2009 Apr 14; 72(15):1322-9. PubMed ID: 19365053
    [Abstract] [Full Text] [Related]

  • 53. Brain metabolite proton T2 mapping at 3.0 T in relapsing-remitting multiple sclerosis.
    Kirov II, Liu S, Fleysher R, Fleysher L, Babb JS, Herbert J, Gonen O.
    Radiology; 2010 Mar 14; 254(3):858-66. PubMed ID: 20177098
    [Abstract] [Full Text] [Related]

  • 54. Early reduction of total N-acetyl-aspartate-compounds in patients with classical vanishing white matter disease. A long-term follow-up MRS study.
    Dreha-Kulaczewski SF, Dechent P, Finsterbusch J, Brockmann K, Gärtner J, Frahm J, Hanefeld FA.
    Pediatr Res; 2008 Apr 14; 63(4):444-9. PubMed ID: 18356755
    [Abstract] [Full Text] [Related]

  • 55. Evidence for relative cortical sparing in benign multiple sclerosis: a longitudinal magnetic resonance imaging study.
    Calabrese M, Filippi M, Rovaris M, Bernardi V, Atzori M, Mattisi I, Favaretto A, Grossi P, Barachino L, Rinaldi L, Romualdi C, Perini P, Gallo P.
    Mult Scler; 2009 Jan 14; 15(1):36-41. PubMed ID: 18755823
    [Abstract] [Full Text] [Related]

  • 56. Evidence for progressive gray matter loss in patients with relapsing-remitting MS.
    Valsasina P, Benedetti B, Rovaris M, Sormani MP, Comi G, Filippi M.
    Neurology; 2005 Oct 11; 65(7):1126-8. PubMed ID: 16217074
    [Abstract] [Full Text] [Related]

  • 57. Cortical lesions in primary progressive multiple sclerosis: a 2-year longitudinal MR study.
    Calabrese M, Rocca MA, Atzori M, Mattisi I, Bernardi V, Favaretto A, Barachino L, Romualdi C, Rinaldi L, Perini P, Gallo P, Filippi M.
    Neurology; 2009 Apr 14; 72(15):1330-6. PubMed ID: 19365054
    [Abstract] [Full Text] [Related]

  • 58. Hippocampal neurochemical pathology in patients at first episode of affective psychosis: a proton magnetic resonance spectroscopic imaging study.
    Blasi G, Bertolino A, Brudaglio F, Sciota D, Altamura M, Antonucci N, Scarabino T, Weinberger DR, Nardini M.
    Psychiatry Res; 2004 Jul 30; 131(2):95-105. PubMed ID: 15313516
    [Abstract] [Full Text] [Related]

  • 59. Brain metabolite profiles of T1-hypointense lesions in relapsing-remitting multiple sclerosis.
    Li BS, Regal J, Soher BJ, Mannon LJ, Grossman RI, Gonen O.
    AJNR Am J Neuroradiol; 2003 Jan 30; 24(1):68-74. PubMed ID: 12533329
    [Abstract] [Full Text] [Related]

  • 60. Distribution of brain sodium accumulation correlates with disability in multiple sclerosis: a cross-sectional 23Na MR imaging study.
    Zaaraoui W, Konstandin S, Audoin B, Nagel AM, Rico A, Malikova I, Soulier E, Viout P, Confort-Gouny S, Cozzone PJ, Pelletier J, Schad LR, Ranjeva JP.
    Radiology; 2012 Sep 30; 264(3):859-67. PubMed ID: 22807483
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.